Met Life Investment Management, LLC Fibrogen Inc Transaction History

Met Life Investment Management, LLC

$17.1 Billion
Q3 2024

44 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$0.73 - $2.73 $21,905 - $81,921	30,008 New	30,008 $70,000
Q2 2023 Apr 29, 2024	BUY	$2.49 - $20.59 $121,111 - $1 Million	48,639 New	48,639 $131,000
Q2 2023 Aug 10, 2023	BUY	$2.49 - $20.59 $3,329 - $27,528	1,337 Added 2.83%	48,639 $131,000
Q1 2023 May 09, 2024	BUY	$15.95 - $25.18 $754,466 - $1.19 Million	47,302 New	47,302 $883 Million
Q1 2022 May 10, 2024	BUY	$12.02 - $16.79 $568,570 - $794,200	47,302 New	47,302 $568,000
Q1 2022 Mar 22, 2023	BUY	$12.02 - $16.79 $202,440 - $282,777	16,842 Added 55.29%	47,302 $568,000
Q1 2022 May 12, 2022	BUY	$12.02 - $16.79 $202,440 - $282,777	16,842 Added 55.29%	47,302 $569,000
Q4 2021 May 17, 2024	BUY	$9.93 - $15.39 $54,793 - $84,922	5,518 Added 22.12%	30,460 $429,000
Q4 2021 Jun 21, 2023	SELL	$9.93 - $15.39 $167,241 - $259,198	-16,842 Reduced 35.61%	30,460 $429,000
Q4 2021 Mar 22, 2023	BUY	$9.93 - $15.39 $54,793 - $84,922	5,518 Added 22.12%	30,460 $429,000
Q4 2021 Feb 15, 2022	BUY	$9.93 - $15.39 $54,793 - $84,922	5,518 Added 22.12%	30,460 $429,000
Q3 2021 May 17, 2024	SELL	$10.18 - $26.64 $71,321 - $186,639	-7,006 Reduced 21.93%	24,942 $254,000
Q3 2021 Jun 21, 2023	SELL	$10.18 - $26.64 $227,624 - $595,670	-22,360 Reduced 47.27%	24,942 $254,000
Q3 2021 Mar 22, 2023	SELL	$10.18 - $26.64 $71,321 - $186,639	-7,006 Reduced 21.93%	24,942 $254,000
Q3 2021 Nov 15, 2021	SELL	$10.18 - $26.64 $71,321 - $186,639	-7,006 Reduced 21.93%	24,942 $255,000
Q2 2021 Jun 21, 2023	SELL	$18.57 - $35.68 $285,123 - $547,830	-15,354 Reduced 32.46%	31,948 $850,000
Q1 2021 May 17, 2024	BUY	$31.0 - $55.72 $60,140 - $108,096	1,940 Added 6.46%	31,948 $1.11 Million
Q1 2021 Jun 26, 2023	SELL	$31.0 - $55.72 $475,974 - $855,524	-15,354 Reduced 32.46%	31,948 $1.11 Billion
Q1 2021 Mar 22, 2023	SELL	$31.0 - $55.72 $74,834 - $134,508	-2,414 Reduced 7.03%	31,948 $1.11 Million
Q1 2021 May 14, 2021	SELL	$31.0 - $55.72 $74,834 - $134,508	-2,414 Reduced 7.03%	31,948 $1.11 Million
Q4 2020 May 24, 2024	SELL	$37.09 - $48.97 $84,342 - $111,357	-2,274 Reduced 6.21%	34,362 $1.27 Million
Q4 2020 Jun 22, 2023	SELL	$37.09 - $48.97 $479,944 - $633,671	-12,940 Reduced 27.36%	34,362 $1.27 Million
Q4 2020 Mar 22, 2023	SELL	$37.09 - $48.97 $84,342 - $111,357	-2,274 Reduced 6.21%	34,362 $1.27 Million
Q4 2020 Feb 16, 2021	SELL	$37.09 - $48.97 $84,342 - $111,357	-2,274 Reduced 6.21%	34,362 $1.27 Million
Q3 2020 Jun 26, 2023	SELL	$40.47 - $45.5 $431,653 - $485,303	-10,666 Reduced 22.55%	36,636 $1.51 Million
Q2 2020 May 24, 2024	BUY	$32.57 - $42.83 $215,873 - $283,877	6,628 Added 22.09%	36,636 $1.48 Billion
Q2 2020 Jun 26, 2023	SELL	$32.57 - $42.83 $347,391 - $456,824	-10,666 Reduced 22.55%	36,636 $1.48 Million
Q2 2020 Mar 22, 2023	BUY	$32.57 - $42.83 $61,752 - $81,205	1,896 Added 5.46%	36,636 $1.48 Million
Q2 2020 Aug 14, 2020	BUY	$32.57 - $42.83 $61,752 - $81,205	1,896 Added 5.46%	36,636 $1.49 Million
Q1 2020 Jul 12, 2023	SELL	$23.3 - $45.96 $292,694 - $577,349	-12,562 Reduced 26.56%	34,740 $1.21 Million
Q4 2019 Jul 12, 2023	SELL	$34.58 - $48.06 $434,393 - $603,729	-12,562 Reduced 26.56%	34,740 $1.49 Million
Q3 2019 Jul 12, 2023	SELL	$36.98 - $48.45 $464,542 - $608,628	-12,562 Reduced 26.56%	34,740 $1.28 Million
Q3 2019 Mar 22, 2023	BUY	$36.98 - $48.45 $51,217 - $67,103	1,385 Added 4.15%	34,740 $1.28 Million
Q3 2019 Nov 14, 2019	BUY	$36.98 - $48.45 $51,217 - $67,103	1,385 Added 4.15%	34,740 $1.29 Million
Q2 2019 Jul 12, 2023	SELL	$35.13 - $55.53 $441,303 - $697,567	-12,562 Reduced 26.56%	34,740 $1.57 Million
Q1 2019 Jul 13, 2023	SELL	$42.83 - $59.91 $597,350 - $835,564	-13,947 Reduced 29.49%	33,355 $1.81 Million
Q4 2018 Jul 13, 2023	SELL	$37.97 - $60.16 $529,567 - $839,051	-13,947 Reduced 29.49%	33,355 $1.54 Million
Q4 2018 Mar 22, 2023	SELL	$37.97 - $60.16 $672,106 - $1.06 Million	-17,701 Reduced 34.67%	33,355 $1.54 Million
Q4 2018 Feb 14, 2019	SELL	$37.97 - $60.16 $672,106 - $1.06 Million	-17,701 Reduced 34.67%	33,355 $1.54 Million
Q3 2018 Jul 13, 2023	SELL	$56.3 - $67.25 $847,878 - $1.01 Million	-15,060 Reduced 31.84%	32,242 $1.96 Million
Q3 2018 Mar 22, 2023	BUY	$56.3 - $67.25 $211,350 - $252,456	3,754 Added 7.94%	51,056 $3.1 Million
Q3 2018 Nov 14, 2018	BUY	$56.3 - $67.25 $954,003 - $1.14 Million	16,945 Added 49.68%	51,056 $3.1 Million
Q2 2018 Aug 15, 2018	BUY	$44.9 - $64.95 $130,703 - $189,069	2,911 Added 9.33%	34,111 $2.14 Million
Q4 2017 Feb 15, 2018	BUY	$41.95 - $60.1 $1.31 Million - $1.88 Million	31,200	31,200 $1.48 Million

Others Institutions Holding FGEN

# of Institutions

Shares Held

47.1M

Call Options Held

387K

Put Options Held

672K

Primecap Management CO Pasadena, CA

9.91M
Shares

$3.47 Million
0.0% of portfolio
Armistice Capital, LLC New York, NY

6.8M
Shares

$2.38 Million
0.05% of portfolio
Vanguard Group Inc Valley Forge, PA

5.88M
Shares

$2.06 Million
0.0% of portfolio
Acadian Asset Management LLC Boston, MA

3.91M
Shares

$1.37 Million
0.0% of portfolio
Black Rock Inc. New York, NY

2.41M
Shares

$843,377
0.0% of portfolio

View Full List

About FIBROGEN INC

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $32.8M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

More about FGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Account